晚期子宫内膜癌治疗启动与生存的种族和民族差异
这项回顾性队列研究利用Flatiron Health数据库纳入2013至2022年诊断为晚期(III-IV期)或复发的子宫内膜癌成年女性4177例,评估治疗启动时间和总生存与种族和民族及社会经济地位(SES)的关联。结果显示,在最低SES五分位地区,非西班牙裔黑人和西班牙裔/拉丁裔患者延迟治疗启动的风险高于非西班牙裔白人;在最高SES五分位地区,非西班牙裔黑人患者的全因死亡风险高于非西班牙裔白人。
要点
- 低SES地区非西班牙裔黑人延迟治疗启动aPR 1.07(95%CI 1.00-1.13)。
- 低SES地区西班牙裔/拉丁裔延迟治疗启动aPR 1.12(95%CI 1.00-1.25)。
- 高SES地区非西班牙裔黑人全因死亡aHR 2.49(95%CI 1.55-4.00)。
核心结论
- 晚期子宫内膜癌患者中,治疗启动和生存的种族和民族差异持续存在,并显著受社会经济因素影响。
研究设计与样本
- 回顾性队列研究,使用Flatiron Health研究数据库,纳入2013至2022年诊断为晚期(III-IV期)或复发的子宫内膜癌成年女性4177例。
主要发现
- 研究人群种族构成为非西班牙裔白人68.1%、非西班牙裔黑人15.2%、西班牙裔/拉丁裔5.3%、非西班牙裔亚裔2.2%。
- 中位治疗启动时间为26天,中位生存时间为3.1年。
- 调整后,在最低SES五分位地区,非西班牙裔黑人和西班牙裔/拉丁裔患者延迟治疗启动风险高于非西班牙裔白人。
- 在最高SES五分位地区,非西班牙裔黑人患者全因死亡风险高于非西班牙裔白人(aHR 2.49,95%CI 1.55-4.00)。
关键数值与推荐
- 延迟治疗启动定义为超过6周。
- 延迟治疗启动关联:低SES地区非西班牙裔黑人aPR 1.07(95%CI 1.00-1.13),西班牙裔/拉丁裔aPR 1.12(95%CI 1.00-1.25),均与非西班牙裔白人比较。
- 全因死亡关联:高SES地区非西班牙裔黑人aHR 2.49(95%CI 1.55-4.00),与非西班牙裔白人比较。
临床怎么用
- 临床中应关注晚期子宫内膜癌患者的种族和民族及社会经济背景,识别延迟治疗启动的高危人群。
- 对低SES地区的非西班牙裔黑人和西班牙裔/拉丁裔患者,可考虑优化治疗启动流程以减少延迟。
- 对高SES地区的非西班牙裔黑人患者,需进一步探究影响生存差异的因素并加强随访管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the associations of time to treatment initiation and overall survival with race and ethnicity by socioeconomic status (SES) among women with advanced endometrial cancer. We also aimed to evaluate the role of social and clinical determinants in time to treatment initiation and overall survival. METHODS: We conducted a retrospective cohort study using the Flatiron Health Research Database among adult women diagnosed with advanced (stages III-IV) endometrial cancer or who developed recurrence between 2013 and 2022. The main outcomes included delayed treatment initiation (more than 6 weeks) and all-cause mortality. Primary exposures included race and ethnicity and quintiles of area-level SES (Yost Index). We computed adjusted prevalence ratios with 95% CIs using multivariable modified Poisson regressions to assess racial and ethnic disparities in time to treatment initiation, and we computed adjusted hazard ratios (HRs) using Cox proportional hazards models to assess disparities in mortality. All models were adjusted for sociodemographic factors, comorbidities, and cancer and histology characteristics. RESULTS: Among the 4,177 women included in this study, the racial and ethnic composition included 68.1% non-Hispanic White, 15.2% non-Hispanic Black, 5.3% Hispanic/Latina, and 2.2% non-Hispanic Asian. The median time to treatment initiation was 26 days, and the median survival time was 3.1 years. After adjustments for participant characteristics, delayed treatment initiation was associated with living in areas of the lowest SES quintile among non-Hispanic Black (adjusted prevalence ratio 1.07, 95% CI, 1.00-1.13) and Hispanic/Latina (adjusted prevalence ratio 1.12, 95% CI, 1.00-1.25) participants compared with non-Hispanic White participants. We observed an inverted moderating effect on all-cause mortality in which non-Hispanic Black participants living in areas of the highest SES quintile had a higher risk of death compared with non-Hispanic White participants (adjusted HR 2.49, 95% CI, 1.55-4.00). CONCLUSION: Our findings demonstrated that racial and ethnic disparities in treatment initiation and survival persist among women with advanced endometrial cancer and are significantly modified by socioeconomic factors.
引用
- Lin YC, Garcia-Rodriguez O, Boxtha C, et al. Racial and Ethnic Disparities in Treatment Initiation and Survival Among Patients With Endometrial Cancer. Obstet Gynecol. 2026. PMID: 42837635. doi:10.1097/AOG.0000000000006443
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。